Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

http://www.wikidata.org/entity/Q33406415

about

Molecular Targeted Intervention for Pancreatic Cancer Current status and progress of pancreatic cancer in China Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancer nab-Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer.Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer.nab-Paclitaxel for the treatment of pancreatic cancer.Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.Bcl-2/Bcl-xL inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death.Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study.Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study.

P2860

Q26798453-E4F17B2D-C80D-48AC-8AE1-DCA47935BD5D Q26799739-09D1E75A-ED99-4D82-9CD3-5CB56F09F585 Q35047386-D89A4B22-BFAC-4C39-9327-F51EA2833149 Q37460932-77DFFAE4-0567-4660-9E67-87E96369E298 Q37577579-103CD396-ECBC-4332-A4DE-0A546CBF2C24 Q37714111-19AD0D16-1937-4BE2-BEB6-06DDDED5D5F8 Q38150356-FB990A16-7A40-468A-B112-D92CE396DD97 Q40977884-5C4568FF-B41E-4E63-8975-5FA50BCC4F11 Q41608480-1424CA3E-2793-46E8-9F46-B05C3903BFC8 Q47112954-01237501-BB19-41AE-876B-EC7FE7224A44 Q47121263-0122D311-03CF-4C4C-9C19-21C3B8446A2E

P2860

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

http://www.wikidata.org/entity/Q33406415

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@ast

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@en

type

label

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@ast

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@en

prefLabel

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@ast

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@en

P1433

Q33406415-BBBD2761-92A8-4C3A-8653-E5E3E16BC7C4

P1476

Q33406415-61239080-01CF-4E08-8BA4-CAAEC050D29A

P2093

Q33406415-162F90DE-7594-4F95-B7C2-8A6545A9C9ED

Q33406415-20B0A663-4027-40DE-94CE-D6E57EA65182

Q33406415-4BDE1220-F5A4-4A02-902F-C689648EAC46

Q33406415-5AF31A21-2EB1-4EC6-9EAB-AA96ED0CA5AB

Q33406415-7745E3ED-8937-4586-843D-C2787B07591A

Q33406415-84980BD8-A1AC-4F3F-B3AF-D0564F7FD98D

Q33406415-86D1C5F9-921D-45D3-90F9-D4075834D6CF

Q33406415-C43B292D-9E9F-4F88-94A0-8868577A38A1

Q33406415-CDF9D1E9-2CC1-4EB7-89BF-004DFECF0055

P2860

Q33406415-1E488EE0-674A-437E-B318-17CEF06379FB

Q33406415-32306690-FCF8-4971-B142-71AD1CD775F2

Q33406415-41989515-D808-4337-B7D3-556BD17ED362

Q33406415-5A4D0619-0AF6-47F8-AF07-07B7A2FDD13D

Q33406415-670BC6F1-5B47-4747-A3C8-DB503FE528DA

Q33406415-75676039-3719-4659-A371-0EAAA33D2D61

Q33406415-8028F5FE-8D85-464F-A30D-E9FF25EA5326

Q33406415-96A0798F-A441-48ED-A6FB-0F1E430A5E52

Q33406415-9FCC47E2-DD34-4724-8D40-121B0C6D6025

Q33406415-A096FD7A-262C-47CE-8F24-484371B0B5BF

P2888

Q33406415-DD527A9E-DBBF-4D2B-A572-D1DD3732C657

P304

Q33406415-133999D8-0B1D-49F6-B6D1-0C222ED50CC0

P31

Q33406415-C75A2BD2-2FBF-4034-87F9-607615DDD204

P356

Q33406415-0F654B15-2215-495C-99A9-1FBE300A4405

P433

Q33406415-9021272D-B52D-4448-9F5F-C1302C1C3E03

P478

Q33406415-729E9CE7-E489-48D4-BC2B-A975BD98A03E

P577

Q33406415-0ECB8B21-3167-4C3D-80FC-FB1FE3127288

P6179

Q33406415-D1D236D9-AE2A-49EB-876F-C91EC75F8C74

P698

Q33406415-27172141-1F64-45FE-8E57-115C122ECB8B

P356

S00280-013-2102-4

P1433

Cancer Chemotherapy and Pharmacology

P1476

Phase I/II study of albumin-bo ...... th advanced pancreatic cancer.

@en

P2093

De-shen Wang

http://www.w3.org/2001/XMLSchema#string

Dong-sheng Zhang

http://www.w3.org/2001/XMLSchema#string

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Feng-hua Wang

http://www.w3.org/2001/XMLSchema#string

Hui-yan Luo

http://www.w3.org/2001/XMLSchema#string

Miao-zhen Qiu

http://www.w3.org/2001/XMLSchema#string

Rui-hua Xu

http://www.w3.org/2001/XMLSchema#string

Yu-hong Li

http://www.w3.org/2001/XMLSchema#string

Zhi-qiang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Are risk factors associated with outcomes in pancreatic cancer?

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

P2888

s00280-013-2102-4

P304

1065-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-013-2102-4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008102215

http://www.w3.org/2001/XMLSchema#string

P698

23483298

http://www.w3.org/2001/XMLSchema#string